Invention Application
- Patent Title: Bonding tissues and cross-linking proteins with naphthalimide compounds
-
Application No.: US15999547Application Date: 2018-08-20
-
Publication No.: US20190241680A1Publication Date: 2019-08-08
- Inventor: Ronald E. Utecht , Kaia L. Kloster , Millard M. Judy , Kevin J. Vaska , James L. Matthews
- Applicant: Alumend, LLC
- Applicant Address: US SD Sioux Falls
- Assignee: Alumend, LLC
- Current Assignee: Alumend, LLC
- Current Assignee Address: US SD Sioux Falls
- Main IPC: C08B37/08
- IPC: C08B37/08 ; A61B17/00 ; A61K41/00 ; A61K47/61 ; A61L24/08 ; A61K8/73 ; A61K31/722 ; A61Q17/04 ; A61Q19/00 ; A61N5/06 ; A61B17/08

Abstract:
Naphthalimide compounds as used in tissue bonding and protein cross-linking applications. When activated by an activating agent, such as light in the 400-500 nm absorption range, the naphthalimide compounds form chemically-reactive species that cross-link proteins, bond connective tissues together, and bone tissues and other biomaterials together. A naphthalimide-labeled biomolecule, such as a naphthalimide-labeled chitosan, is also capable of bonding tissues without subsequent direct illumination of the contacted tissue area. The naphthalimide compounds may be used in tissue or arterial repair, stabiliation of an expanded arterial wall after angioplasty, tethering pharmaceutical agents to tissue surfaces to provide local drug delivery, and for chemically bonding skin care products, sunscreens, and cosmetics to the skin.
Public/Granted literature
- US10851185B2 Bonding tissues and cross-linking proteins with naphthalimide compounds Public/Granted day:2020-12-01
Information query